Table 1 Immunoreactivity in human MS Lesions
From: Endogenously regulated Dab2 worsens inflammatory injury in experimental autoimmune encephalomyelitis
|  | Marker (μ ± SD) | ||
|---|---|---|---|
Lesion type | Dab2 +ve cells2 | CD68 +ve cells | APP +ve elements |
Early active – biopsy 1 | 129.9 ± 25.5 | 164.1 ±28.3 | 24.2 ± 5.8 |
Early active – biopsy 2 | 86.4 ± 7.7 | 96.9 ± 12.3 | 23 ± 4.2 |
Late active – biopsy 3 | 10.1 ± 4.1 | 96.9 ± 19.7 | 4.9 ± 3.6 |
Chronic active – autopsy 1 | 0.64 ± 1.0 | 58.7 ± 15.8 | 4.2 ± 1.9 |
Chronic active – autopsy 2 | 0.20 ± 0.42 | 14.0 ± 4.1 | 2.6 ± 0.97 |
Chronic active – autopsy 3 | 0.10 ± 0.32 | 12.8 ± 4.1 | 1.8 ± 1.2 |